BioRestorative Therapies (BRTX) Interest Income - Net (2022 - 2025)
BioRestorative Therapies' (BRTX) quarterly Interest Income - Net came in at $34586.0 in Q4 2025, down 70.93% YoY from $118988.0 in Q4 2024, and down 40.1% on a QoQ basis from $57740.0 in Q3 2025.
BioRestorative Therapies (BRTX) Interest Income - Net (2022 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 4 years of Interest Income - Net data on file, last reported at $34586.0 in Q4 2025.
- Quarterly Interest Income - Net fell 70.93% year-over-year to $34586.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $266207.0 (down 56.79% YoY) and the FY2025 annual result came in at $266207.0, down 56.79% from the prior year.
- Interest Income - Net eased to $34586.0 in Q4 2025, from $57740.0 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of $376223.0 in Q4 2023 to a low of -$46613.0 in Q2 2022.
- A 4-year average of $90389.2 and a median of $85051.0 in 2023 frame the typical range for Interest Income - Net.
- Annual changes were most pronounced in 2024 — Interest Income - Net jumped 792.61% — and 2025, when it tumbled 70.93%.
- Tracing BRTX's Interest Income - Net over 4 years: stood at $116115.0 in 2022, then surged by 224.01% to $376223.0 in 2023, then sank by 68.37% to $118988.0 in 2024, then plunged by 70.93% to $34586.0 in 2025.
- The last three Interest Income - Net figures came in at $34586.0 (Q4 2025), $57740.0 (Q3 2025), and $73915.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | 34,586.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34,586.00 |
| Sep 30, 2025 | 57,740.00 |
| Jun 30, 2025 | 73,915.00 |
| Mar 31, 2025 | 99,966.00 |
| Dec 31, 2024 | 118,988.00 |
| Sep 30, 2024 | 158,547.00 |
| Jun 30, 2024 | 175,945.00 |
| Mar 31, 2024 | 162,597.00 |
| Dec 31, 2023 | 376,223.00 |
| Sep 30, 2023 | 61,667.00 |
| Jun 30, 2023 | 96,187.00 |
| Mar 31, 2023 | 18,216.00 |
| Dec 31, 2022 | 116,115.00 |
| Sep 30, 2022 | -28,841.00 |
| Jun 30, 2022 | -46,613.00 |
| Mar 31, 2022 | -29,011.00 |